|  Help  |  About  |  Contact Us

Publication : Regulatory effects of TLR2 on megakaryocytic cell function.

First Author  Beaulieu LM Year  2011
Journal  Blood Volume  117
Issue  22 Pages  5963-74
PubMed ID  21454454 Mgi Jnum  J:174725
Mgi Id  MGI:5140668 Doi  10.1182/blood-2010-09-304949
Citation  Beaulieu LM, et al. (2011) Regulatory effects of TLR2 on megakaryocytic cell function. Blood 117(22):5963-74
abstractText  TLR2, a functional, inflammatory-related receptor, is known to be expressed on megakaryocytes and platelets and to lead to infection and immune-mediated activation of platelets; however, the role of this receptor in megakaryocytes is not understood. Using Meg-01 cells and mouse megakaryocytes, we found that NFkappaB, ERK-MAPK, and PI3K/Akt pathways, known downstream pathways of TLRs, are activated by Pam3CSK4, a TLR2-specific ligand. In addition, transcription factors associated with megakaryocyte maturation, GATA-1, NF-E2, and mammalian target of rapamycin (mTOR), are all increased in the presence of Pam3CSK4. The effect of Pam3CSK4 on megakaryocyte maturation was verified by the increase in DNA content and adhesion to extracellular matrix proteins by TLR2-dependent stimulation. In addition, TLR2 stimulation resulted in an increase in reactive oxygen species (ROS) production. Gene expression and protein levels of GP1b, CD41, MCP-1, COX2, NFkappaB1, and TLR2 were up-regulated in megakaryocytes after TLR2 stimulation through NFkappaB, PI3K/Akt, and ERK-MAPK pathways. Treatment of wild-type mice with Pam3CSK4 resulted in a return to normal platelet levels and an increase in megakaryocyte maturation, which did not occur in the TLR2(-/-) mice. Therefore, inflammation, through TLR2, can increase maturation and modulate the phenotype of megakaryocytes, contributing to the interrelationship between inflammation and hemostasis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression